The SLC6A7 gene helps move proline, a protein building block, into nerve cells, especially in the brain, where it supports signaling and normal brain function. This gene helps your body recycle proline after nerve cells communicate. If it does not work properly, brain signaling may be less balanced, which can affect development, learning, or behavior. The SLC6A7 gene is mainly discussed in medical and genetics research rather than public culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. You can find more detailed information on this topic in the LearnHub.
Overview
SLC6A7Gene function
What if the gene works
The SLC6A7 gene helps nerve cells move proline, an amino acid, back into cells. It is especially active in the brain and supports signaling between neurons.
Risk
What if the gene does not work
Changes in the SLC6A7 gene can range from milder to more severe and may reduce how well nerve cells recapture proline, a building block and signaling helper. This can disrupt communication between brain cells.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to a pathogenic variant in the SLC6A7 gene is currently established in clinical guidelines. Research is exploring how the SLC6A7 gene affects brain signaling and whether it could become a future drug target or biomarker in neurologic and psychiatric conditions.
Gene function
What if the gene works
In the brain, the SLC6A7 gene helps move the amino acid L-proline into nerve cells. Its protein sits in the cell membrane and works like a gate for this molecule. Understanding how the SLC6A7 gene works in nerve cells helps explain how everyday brain signaling stays steady.
The SLC6A7 gene makes a transport protein that brings L-proline into nerve cells. This helps cells take up an amino acid that is part of normal brain chemistry.
Near synapses (the contact points between nerve cells), this transporter helps regulate L-proline levels around the cell. That supports smooth, controlled chemical signaling between nearby nerve cells.
Its protein uses sodium and chloride, two natural body salts, to move L-proline across the cell membrane. This powers efficient transport during routine nerve cell activity.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Research on how variants in the SLC6A7 gene affect transporter activity suggests that some changes reduce how well the transporter folds, reaches the cell surface, or moves proline into nerve cells. Milder variants may leave partial activity, while more severe variants can greatly lower transport or stop it altogether. Some DNA changes may also weaken the transporter’s stability or its response to sodium, which helps drive transport.
How variants are linked to conditions
Variants in the SLC6A7 gene do not yet have a broadly confirmed link to a specific health condition, though this may change as research develops. Current evidence on how SLC6A7 gene variants are linked to conditions is still evolving, so anyone with a confirmed SLC6A7-related diagnosis should rely on guidance from their doctor or genetic counselor.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences are part of the picture. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC6A7 gene. Anyone with questions about their personal or family risk can talk with a doctor or a genetic counselor.
Inheritance of SLC6A7 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the SLC6A7 gene, so how variants of the SLC6A7 gene are inherited in relation to a defined medical condition is still being clarified. The SLC6A7 gene is located on chromosome 5, which is an autosome, so each person inherits one copy from their mother and one copy from their father. This means any SLC6A7 variant can be passed through either side of the family.
What does my SLC6A7 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the SLC6A7 gene, and this picture may become clearer as research grows. If you have a specific SLC6A7 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC6A7 gene, doctors use genetic testing for SLC6A7 variants on a blood or saliva sample. A lab reads the gene’s DNA code and compares it with the usual sequence to identify variants, which may be reported as benign, uncertain, or disease-causing.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC6A7-specific reason to get genetic testing in routine care. Decisions about testing are usually based on your symptoms, family history, and guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can be informative, but how much it reveals depends on the specific condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also affect how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. By studying the relationship between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes influence both how strongly a drug works and how the body handles it. Understanding this can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC6A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
SLC6A7 was identified during the wave of gene discovery that expanded rapidly in the late 1990s and early 2000s, when researchers were mapping many members of the solute carrier family. Early work placed it among genes involved in moving small molecules across cell membranes, which helped scientists classify it more clearly. As medical science evolved, so did understanding of this gene. Later studies focused on where it is active in the brain and how it fits into broader research on nerve cell signaling. Unlike some genes that entered public discussion through major health stories, SLC6A7 has remained mostly a research gene, known mainly within neuroscience and genetics. Its history is a steady example of how careful laboratory work gradually builds knowledge over time.